| Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial J Trigo, V Subbiah, B Besse, V Moreno, R López, MA Sala, S Peters, ... The lancet oncology 21 (5), 645-654, 2020 | 349 | 2020 |
| Antitumor activity of lurbinectedin (PM01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase I study E Calvo, V Moreno, M Flynn, E Holgado, ME Olmedo, MPL Criado, ... Annals of Oncology 28 (10), 2559-2566, 2017 | 87 | 2017 |
| SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC)(2019) M Dómine, T Moran, D Isla, JL Martí, I Sullivan, M Provencio, ME Olmedo, ... Clinical and Translational Oncology 22, 245-255, 2020 | 59 | 2020 |
| Recomendaciones SEPAR de diagnóstico y tratamiento del cáncer de pulmón de células no pequeñas FV Álvarez, IM Trueba, JB Sanchis, LM López-Rodó, PMR Suárez, ... Archivos de Bronconeumología 52, 2-62, 2016 | 51 | 2016 |
| Treating KRAS-mutant NSCLC: latest evidence and clinical consequences P Garrido, ME Olmedo, A Gómez, L Paz Ares, F López-Ríos, ... Therapeutic Advances in Medical Oncology 9 (9), 589-597, 2017 | 49 | 2017 |
| Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open … SP Aix, TE Ciuleanu, A Navarro, S Cousin, L Bonanno, EF Smit, ... The Lancet Respiratory Medicine 11 (1), 74-86, 2023 | 46 | 2023 |
| Recommendations of the Spanish Society of Pneumology and Thoracic Surgery on the diagnosis and treatment of non-small-cell lung cancer FV Álvarez, IM Trueba, JB Sanchis, LM López-Rodó, PMR Suárez, ... Archivos de bronconeumologia 52, 2-62, 2016 | 39 | 2016 |
| Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer J Zugazagoitia, M Biosca, J Oliveira, ME Olmedo, M Dómine, E Nadal, ... European Respiratory Journal 51 (5), 2018 | 38 | 2018 |
| Efficacy of immunotherapy in sarcomatoid lung cancer, a case report and literature review MP Kotlowska, AG Rueda, ME Olmedo, A Benito, AS Roldán, ... Respiratory medicine case reports 26, 310-314, 2019 | 34 | 2019 |
| Antitumor activity of lurbinectedin in second-line small cell lung cancer patients who are candidates for re-challenge with the first-line treatment V Subbiah, L Paz-Ares, B Besse, V Moreno, S Peters, MA Sala, ... Lung Cancer 150, 90-96, 2020 | 31 | 2020 |
| Executive summary of the SEPAR recommendations for the diagnosis and treatment of non-small cell lung cancer FV Álvarez, IM Trueba, JB Sanchis, LM López-Rodó, PMR Suárez, ... Archivos de Bronconeumología (English Edition) 52 (7), 378-388, 2016 | 30 | 2016 |
| PL02. 03 lurbinectedin/doxorubicin versus CAV or topotecan in relapsed SCLC patients: phase III randomized ATLANTIS trial L Paz-Ares, T Ciuleanu, A Navarro, A Fulop, S Cousin, L Bonanno, E Smit, ... Journal of Thoracic Oncology 16 (10), S844-S845, 2021 | 27 | 2021 |
| Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial. LG Paz-Ares, JM Trigo Perez, B Besse, V Moreno, R Lopez, MA Sala, ... Journal of Clinical Oncology 37 (15_suppl), 8506-8506, 2019 | 26 | 2019 |
| Targeting KRAS in non-small cell lung cancer E Corral de la Fuente, ME Olmedo Garcia, A Gomez Rueda, Y Lage, ... Frontiers in Oncology 11, 792635, 2022 | 24 | 2022 |
| Tumour lysis syndrome in solid tumors: clinical characteristics and prognosis F Caravaca-Fontán, O Martínez-Sáez, S Pampa-Saico, ME Olmedo, ... Medicina Clínica (English Edition) 148 (3), 121-124, 2017 | 22 | 2017 |
| Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments A Cortés, JL Casado, F Longo, JJ Serrano, C Saavedra, H Velasco, ... European journal of cancer 166, 229-239, 2022 | 21 | 2022 |
| High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1 N Muñoz-Unceta, J Zugazagoitia, A Manzano, E Jiménez-Aguilar, ... European Journal of Cancer 141, 193-198, 2020 | 20 | 2020 |
| Parvimonas micra chest wall abscess following transthoracic lung needle biopsy L Gorospe, I Bermudez-Coronel-Prats, CF Gomez-Barbosa, ... The Korean Journal of Internal Medicine 29 (6), 834, 2014 | 16 | 2014 |
| Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group J Remon, E Nadal, M Dómine, J Ruffinelli, Y García, JC Pardo, R López, ... Lung Cancer 147, 83-90, 2020 | 15 | 2020 |
| Efficacy and safety of lurbinectedin and doxorubicin in relapsed small cell lung cancer. Results from an expansion cohort of a phase I study ME Olmedo, M Forster, V Moreno, MP López-Criado, I Braña, M Flynn, ... Investigational New Drugs 39, 1275-1283, 2021 | 10 | 2021 |
